Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Microbes Infect ; 14(11): 968-78, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22546527

RESUMO

No commercially live vaccine against cholera caused by Vibrio cholerae O139 serogroup is available and it is currently needed. Virulent O139 strain CRC266 was genetically modified by firstly deleting multiple copies of the filamentous phage CTXφ, further tagging by insertion of the endoglucanase A coding gene from Clostridium thermocellum into the hemagglutinin/protease gene and finally deleting the mshA gene, just to improve the vaccine biosafety. One of the derived strains designated as TLP01 showed full attenuation and good colonizing capacity in the infant mouse cholera model, as well as highly immunogenic properties in the adult rabbit and rat models. Since TLP01 lacks MSHA fimbriae, it is refractory to infection with another filamentous phage VGJφ and therefore protected of acquiring CTXφ from a recombinant hybrid VGJφ/CTXφ. This strategy could reduce the possibilities of stable reversion to virulence out of the human gut. Furthermore, this vaccine strain was impaired to produce biofilms under certain culture conditions, which might have implications for the strain survival in natural settings contributing to vaccine biosafety as well. The above results has encouraged us to consider TLP01 as a live attenuated vaccine strain having an adequate performance in animal models, in terms of attenuation and immunogenicity, so that it fulfills the requirements to be evaluated in human volunteers.


Assuntos
Vacinas contra Cólera/imunologia , Proteínas de Fímbrias/imunologia , Vibrio cholerae O139/imunologia , Administração Oral , Animais , Anticorpos Antibacterianos/imunologia , Derrame de Bactérias , Sequência de Bases , Biofilmes , Cólera/imunologia , Cólera/prevenção & controle , Vacinas contra Cólera/genética , Vacinas contra Cólera/farmacologia , Modelos Animais de Doenças , Fezes/microbiologia , Proteínas de Fímbrias/genética , Mucosa Intestinal/imunologia , Lectina de Ligação a Manose/genética , Lectina de Ligação a Manose/imunologia , Dados de Sequência Molecular , Coelhos , Ratos , Ratos Sprague-Dawley , Alinhamento de Sequência , Deleção de Sequência/genética , Estatísticas não Paramétricas , Vacinas Atenuadas/genética , Vacinas Atenuadas/imunologia , Vacinas Atenuadas/farmacologia , Vibrio cholerae O139/genética
2.
J Bacteriol ; 191(18): 5873-6, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19617366

RESUMO

The native product of open reading frame 112 (orf112) and a recombinant variant of the RstB protein, encoded by Vibrio cholerae pathogen-specific bacteriophages VGJphi and CTXphi, respectively, were purified to more than 90% homogeneity. Orf112 protein was shown to specifically bind single-stranded genomic DNA of VGJphi; however, RstB protein unexpectedly bound double-stranded DNA in addition to the single-stranded genomic DNA. The DNA binding properties of these proteins may explain their requirement for the rolling circle replication of the respective phages and RstB's requirement for single-stranded-DNA chromosomal integration of CTXphi phage dependent on XerCD recombinases.


Assuntos
Bacteriófagos/metabolismo , Proteínas de Ligação a DNA/metabolismo , Inovirus/metabolismo , Vibrio cholerae/virologia , Proteínas Virais/metabolismo , Integração Viral , Sítios de Ligação Microbiológicos , Bacteriófagos/classificação , Bacteriófagos/genética , DNA/metabolismo , DNA de Cadeia Simples/metabolismo , Proteínas de Ligação a DNA/genética , Eletroforese em Gel de Poliacrilamida , Regulação Viral da Expressão Gênica , Inovirus/classificação , Inovirus/genética , Fases de Leitura Aberta/genética , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Proteínas Virais/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA